Evidence map›Paper›PMID 31076509›Full record

ArticleThe Journal of biological chemistry2019

Formation of mammalian preribosomes proceeds from intermediate to composed state during ribosome maturation.

Danysh A Abetov, Vladimir S Kiyan, Assylbek A Zhylkibayev, Dilara A Sarbassova, Sanzhar D Alybayev, Eric Spooner, Min Sup Song, Rakhmetkazhy I Bersimbaev, Dos D Sarbassov

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. The Prognostic and Biological Value of PGF-Based H&E Pathomics in Hepatocellular Carcinoma.Liver international : official journal of the International Association for the Study of the Liver · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. LYAR Promotes Colorectal Cancer Progression by UpregulatingOxidative medicine and cellular longevity · 2021
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Danysh A AbetovDepartment of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030.
Vladimir S KiyanDepartment of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030.
Assylbek A ZhylkibayevDepartment of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030.
Dilara A SarbassovaDepartment of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030.
Sanzhar D AlybayevDepartment of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030.
Eric SpoonerWhitehead Institute for Biomedical Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02142.
Min Sup SongDepartment of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030; MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas 77030.
Rakhmetkazhy I BersimbaevDepartment of Natural Sciences, L. N. Gumilyov Eurasian National University, Nur-Sultan 010000, Kazakhstan, and.
Dos D SarbassovDepartment of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030; MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas 77030,; Department of Biology, Nazarbayev University, Nur-Sultan 010000, Kazakhstan. Electronic address: dos.sarbassov@nu.edu.kz.
The University of Texas MD Anderson Cancer Center · USL. N. Gumilyov Eurasian National University · KZWhitehead Institute for Biomedical Research · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
The role of PTEN feedback mechanism in cancerR01CA196740 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Min Sup Song · 2016 to 2026
$3.4M
NCI NIH HHS P30 CA016672NCI NIH HHS R01 CA196740
6 · The paper itself

Abstract

In eukaryotes, ribosome assembly is a rate-limiting step in ribosomal biogenesis that takes place in a distinctive subnuclear organelle, the nucleolus. How ribosomes get assembled at the nucleolar site by forming initial preribosomal complexes remains poorly characterized. In this study, using several human and murine cell lines, we developed a method for isolation of native mammalian preribosomal complexes by lysing cell nuclei through mild sonication. A sucrose gradient fractionation of the nuclear lysate resolved several ribonucleoprotein (RNP) complexes containing rRNAs and ribosomal proteins. Characterization of the RNP complexes with MS-based protein identification and Northern blotting-based rRNA detection approaches identified two types of preribosomes we named here as intermediate preribosomes (IPRibs) and composed preribosome (CPRib). IPRib complexes comprised large preribosomes (105S to 125S in size) containing the rRNA modification factors and premature rRNAs. We further observed that a distinctive CPRib complex consists of an 85S preribosome assembled with mature rRNAs and a ribosomal biogenesis factor, Ly1 antibody-reactive (LYAR), that does not associate with premature rRNAs and rRNA modification factors. rRNA-labeling experiments uncovered that IPRib assembly precedes CPRib complex formation. We also found that formation of the preribosomal complexes is nutrient-dependent because the abundances of IPRib and CPRib decreased substantially when cells were either deprived of amino acids or exposed to an mTOR kinase inhibitor. These findings indicate that preribosomes form via dynamic and nutrient-dependent processing events and progress from an intermediate to a composed state during ribosome maturation.

Indexed as

AnimalsCell LineDNA-Binding ProteinsHumansMiceN-Terminal AcetyltransferasesRibonucleoproteinsRibosomal ProteinsRibosomesRNA PrecursorsRNA Processing, Post-TranscriptionalRNA, RibosomalTOR Serine-Threonine KinasesDNA-Binding ProteinsN-Terminal AcetyltransferasesRibonucleoproteinsRibosomal ProteinsRNA PrecursorsRNA, RibosomalTOR Serine-Threonine Kinasesgradient fractionationmammalian target of rapamycin (mTOR)precursor ribosomal RNA (pre-rRNA)pre-ribosomal complexesribosomal biogenesis factorsribosomal proteinsribosomal ribonucleic acid (rRNA) (ribosomal RNA)ribosomal RNA processing (rRNA processing)rRNA processingsubcellular fractionation

Identifiers

PMID31076509
PMCPMC6635442
OpenAlexW2944473293

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.